CorVel Corp director Alan Hoops sells $582,037 in stock

Alan Hoops, a director at CorVel Corp (NASDAQ:CRVL), recently sold shares worth $582,037. The transactions, which took place on February 7, involved the sale of 4,800 shares of common stock. The sale price ranged from $121.1019 to $121.289 per share. The stock, currently trading near $118, has shown impressive momentum with a 44% return over the past year. According to InvestingPro analysis, CorVel appears to be trading above its Fair Value, with the company maintaining a "GREAT" overall financial health score.

Following these transactions, Hoops holds 19,688 shares directly and 128,413 shares indirectly through the Hoops Irrevocable Trust. The sales were executed in two separate transactions, including one for 4,000 shares and another for 800 shares. With a market capitalization of $6 billion and revenue growth of 12.6% in the last twelve months, CorVel continues to demonstrate strong business fundamentals. InvestingPro subscribers can access 8 additional key insights about CorVel’s valuation and growth prospects in the comprehensive Pro Research Report.

In other recent news, CorVel Corporation has demonstrated robust financial growth in its Q4 2024 performance. The company’s earnings per share (EPS) saw a significant increase of 39%, reaching $0.46. At the same time, revenues climbed by 13% to hit a total of $228 million. One of the key factors contributing to this success is CorVel’s continued focus on technological innovation, notably in AI and automation within healthcare services. The company also completed a 3-for-1 stock split in December 2024.

CorVel’s actual EPS and revenue surpassed market expectations, contributing to a positive reaction from investors. The company’s unique development team and proprietary CareMC system have played a crucial role in maintaining its competitive edge in the industry. Looking forward, CorVel remains committed to expanding its AI and automation capabilities, with a focus on improving patient outcomes and operational efficiency.

As per analysts, CorVel projects continued growth, with EPS forecasts for FY2025 and FY2026 set at $1.76 and $1.82, respectively. Revenue projections for the same periods are $854.96 million and $884.88 million. These recent developments underline the company’s strategic direction and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.